Skip to main content
. 2020 Nov 26;21:975. doi: 10.1186/s13063-020-04868-0

Table 2.

Outcomes and assessment points

Variables Measurement Screening t0 t1 t2 t3
Inclusion/exclusion criteria
 Inclusion/exclusion criteria SRQ x
 Mindfulness FMI x
Primary outcome
 Mindfulness FMI x
Secondary outcomes
 Mindfulness FMI x x x
 Depressive symptoms PHQ-9 x x x x
 Anxiety GAD-7 x x x x
 Stress PSS-4 x x x x
 Well-being WHO-5 x x x x
 Presenteeism PSS x x x
 Interoceptive sensibility BPQ x x x
 Self-efficacy SES x x x x
 Cognitive fusion CFQ-D x x x x
 Emotion regulation ERQ x x x x
 Alexithymia TAS-20 x x x x
 Intervention adherence Intervention dropout x x x
 Intervention satisfaction CSQ-8 x*
 Side effects of intervention INEP* x x
Covariates
 Demographic variables SRQ x
 Previous experience with mindfulness, use of additional treatment options SRQ x x x
 Treatment expectation CEQ x

Note. CEQ Client Expectancy Questionnaire, CFQ-D Cognitive Fusion Questionnaire, CSQ-8 Client Satisfaction Questionnaire, German Version ZUF-8, ERQ Emotion Regulation Questionnaire, FMI Freiburg Mindfulness Inventory, GAD-7 Generalized Anxiety Disorder Questionnaire, INEP Inventory for the Assessment of Negative Effects of Psychotherapy, BPQ Body Perception Questionnaire, Awareness Section, PHQ-9 Patient Health Questionnaire, PSS Presenteeism Scale for Students, PSS-4 Short Form Perceived Stress Scale, SES Self-Efficacy Scale, SRQ Self-Report Assessment Questionnaire, TAS-20 Toronto-Alexithymia Scale, WHO-5 World Health Organization Well-Being Index

*Intervention groups only (UG, GoD)